New atypical antipsychotic medications
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 32 (3-4) , 215-228
- https://doi.org/10.1016/s0022-3956(98)00023-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neurocognitive Impairment in Schizophrenia and how it Affects Treatment OptionsThe Canadian Journal of Psychiatry, 1997
- Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophreniaJournal of Psychopharmacology, 1997
- P-15-1: Long-term safety of risperidoneEuropean Neuropsychopharmacology, 1996
- The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomographyPsychopharmacology, 1996
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Positive and negative symptoms covary during clozapine treatment in schizophreniaJournal of Psychiatric Research, 1993
- Seroquel: biochemical profile of a potential atypical antipsychoticPsychopharmacology, 1993
- PHARMACOLOGICAL PROFILE OF THE ATYPICAL NEUROLEPTIC SERTINDOLEClinical Neuropharmacology, 1992
- ClozapineNew England Journal of Medicine, 1991
- The effects of neuroleptics on neuropsychological test results of schizophrenicsArchives of Clinical Neuropsychology, 1988